Data / Drug companies / Mood Stabilizer
Mood Stabilizer drugs: 21 drugs from 130 companies in the FDA NDC directory
Mood Stabilizer is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 885 products in this class from 130 companies, covering 21 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 19, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 130Companies
- 885Products
- 21Drugs by generic name
Drugs in the Mood Stabilizer class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Carbamazepine | 154 | 52 |
| Lamotrigine | 262 | 51 |
| Divalproex sodium | 195 | 48 |
| Lithium carbonate | 73 | 24 |
| Valproic acid | 30 | 21 |
| Lithium | 6 | 5 |
| Lamotrigine extended-release | 15 | 4 |
| Valproate sodium | 5 | 3 |
| Lithium bromatum | 9 | 2 |
| Lithium carbonicum | 8 | 2 |
| Lithium phosphoricum | 17 | 1 |
| Lithium metallicum | 9 | 1 |
| Lithium muriaticum | 8 | 1 |
| Lithium sulphuratum | 8 | 1 |
| Lamotirigine | 6 | 1 |
| Carbamazepine er | 3 | 1 |
| Lamotrigine chewable dispersible | 2 | 1 |
| Lamotrigine er | 2 | 1 |
| Divalproex sodium d/r | 1 | 1 |
| Divalproex sodium er | 1 | 1 |
| Lithium citrate | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hahnemann Laboratories, Inc. | 73 | pellet | Unapproved homeopathic products | August 17, 2023 |
| Remedyrepack Inc. | 63 | tablet; tablet, extended release | Generic drugs (ANDA) | July 19, 2026 |
| Bryant Ranch Prepack | 32 | tablet; tablet, delayed release | Generic drugs (ANDA) | June 26, 2024 |
| Alembic Pharmaceuticals Inc. | 22 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | March 2, 2026 |
| Alembic Pharmaceuticals Limited | 22 | tablet; tablet, extended release | Generic drugs (ANDA) | March 2, 2026 |
| Coupler LLC | 22 | tablet; tablet, delayed release | Generic drugs (ANDA) | October 19, 2026 |
| A-S Medication Solutions | 20 | tablet; tablet, delayed release | Generic drugs (ANDA) | June 26, 2024 |
| Deseret Biologicals, Inc. | 20 | liquid | Unapproved homeopathic products | April 10, 2026 |
| Dr. Reddy's Laboratories Limited | 18 | tablet, extended release; tablet | Generic drugs (ANDA) | September 6, 2018 |
| Zydus Pharmaceuticals USA Inc. | 18 | tablet, extended release; tablet | Generic drugs (ANDA) | May 14, 2020 |
| GlaxoSmithKline LLC | 17 | tablet, film coated, extended release; tablet, orally disintegrating | New drug applications (NDA) | August 15, 2011 |
| Torrent Pharmaceuticals Limited | 16 | tablet, extended release; tablet | Generic drugs (ANDA) | January 8, 2026 |
| American Health Packaging | 15 | tablet, extended release; tablet, delayed release | Generic drugs (ANDA) | September 29, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 15 | tablet; tablet, delayed release | Generic drugs (ANDA) | June 26, 2024 |
| Sun Pharmaceutical Industries, Inc. | 15 | tablet; tablet, extended release | Generic drugs (ANDA) | March 1, 2026 |
| NorthStar Rx LLC | 14 | tablet, extended release; tablet | Generic drugs (ANDA) | November 17, 2021 |
| Hikma Pharmaceuticals USA Inc. | 13 | capsule, gelatin coated; tablet | New drug applications (NDA) | August 16, 2026 |
| Cardinal Health 107, LLC | 12 | tablet; tablet, delayed release | Generic drugs (ANDA) | October 7, 2026 |
| Major Pharmaceuticals | 12 | tablet; tablet, delayed release | Generic drugs (ANDA) | August 3, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 11 | tablet, film coated, extended release; tablet, delayed release | Generic drugs (ANDA) | June 2, 2014 |
| Aurobindo Pharma Limited | 11 | tablet; tablet, delayed release | Generic drugs (ANDA) | October 24, 2014 |
| AvKARE | 11 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | February 25, 2022 |
| Camber Pharmaceuticals, Inc. | 11 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | September 26, 2023 |
| American Health Packaging | 10 | tablet; tablet, delayed release | Generic drugs (ANDA) | June 2, 2023 |
| BioActive Nutritional, Inc. | 10 | liquid; spray | Unapproved homeopathic products | January 21, 2026 |
| Preferred Pharmaceuticals Inc. | 10 | tablet; tablet, delayed release | Generic drugs (ANDA) | September 24, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | 10 | tablet; tablet, delayed release | Generic drugs (ANDA) | November 1, 2022 |
| Energique, Inc. | 9 | liquid; spray | Unapproved homeopathic products | June 25, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 9 | tablet, extended release; capsule, gelatin coated | Generic drugs (ANDA) | September 18, 2020 |
| Zydus Lifesciences Limited | 9 | tablet; tablet, chewable | Generic drugs (ANDA) | January 27, 2009 |
| Zydus Lifesciences Limited | 9 | tablet, extended release | Generic drugs (ANDA) | May 14, 2020 |
| Ajanta Pharma USA Inc. | 8 | tablet, orally disintegrating; tablet, extended release | Generic drugs (ANDA) | March 24, 2023 |
| Amneal Pharmaceuticals LLC | 8 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | November 30, 2018 |
| Amneal Pharmaceuticals of New York LLC | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | December 27, 2018 |
| Ascend Laboratories, LLC | 7 | tablet; tablet, extended release | Generic drugs (ANDA) | November 1, 2025 |
| BluePoint Laboratories | 7 | tablet, film coated, extended release; tablet, delayed release | Generic drugs (ANDA) | June 6, 2025 |
| Bryant Ranch Prepack | 7 | tablet, delayed release; tablet, film coated, extended release | Generic drugs (ANDA) | June 2, 2014 |
| Chartwell RX, LLC | 7 | tablet, extended release; suspension | Generic drugs (ANDA) | March 31, 2022 |
| Direct_Rx | 7 | tablet; tablet, extended release | Generic drugs (ANDA) | July 28, 2025 |
| Glenmark Pharmaceuticals Inc., USA | 7 | capsule; tablet, chewable | Generic drugs (ANDA) | February 14, 2011 |
| Jubilant Cadista Pharmaceuticals Inc. | 7 | tablet; tablet, extended release | Generic drugs (ANDA) | August 20, 2022 |
| Professional Complementary Health Formulas | 7 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Upsher-Smith Laboratories, LLC | 7 | tablet, extended release; tablet, delayed release | Generic drugs (ANDA) | April 13, 2021 |
| AbbVie Inc. | 6 | tablet, delayed release; tablet, extended release | New drug applications (NDA) | June 30, 2023 |
| AvPAK | 6 | capsule, extended release; tablet, extended release | Generic drugs (ANDA) | October 13, 2025 |
| Bryant Ranch Prepack | 6 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | August 20, 2022 |
| Owp Pharmaceuticals, Inc. | 6 | tablet; suspension | Generic drugs (ANDA) | October 1, 2025 |
| Yiling Pharmaceutical, Inc. | 6 | tablet, film coated, extended release | Generic drugs (ANDA) | December 9, 2021 |
| Advagen Pharma Ltd | 5 | tablet; solution | Generic drugs (ANDA) | August 14, 2023 |
| Ani Pharmaceuticals, Inc. | 5 | capsule, extended release; solution | Generic drugs (ANDA) | April 13, 2026 |
| Atlantic Biologicals Corp. | 5 | capsule, coated pellets; tablet, delayed release | Generic drugs (ANDA) | November 9, 2022 |
| Bionpharma Inc. | 5 | tablet, delayed release; tablet | Generic drugs (ANDA) | June 26, 2024 |
| Lupin Pharmaceuticals, Inc. | 5 | tablet, delayed release; tablet, extended release | Generic drugs (ANDA) | September 18, 2020 |
| NorthStar RxLLC | 5 | tablet, extended release; solution | Generic drugs (ANDA) | February 24, 2026 |
| Novartis Pharmaceuticals Corporation | 5 | tablet, extended release; suspension | New drug applications (NDA) | March 25, 1996 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet; tablet, delayed release | Generic drugs (ANDA) | November 1, 2022 |
| Pai Holdings, LLC DBA Pai Pharma | 5 | solution | Generic drugs (ANDA) | April 14, 2026 |
| Rising Pharma Holdings, Inc. | 5 | tablet, extended release; tablet, chewable | Generic drugs (ANDA) | April 24, 2020 |
| Umedica Laboratories USA Inc. | 5 | tablet, extended release; tablet | Generic drugs (ANDA) | August 20, 2022 |
| Actavis Pharma, Inc. | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | June 1, 2016 |
| Apotex Corp. | 4 | capsule, extended release; tablet | Generic drugs (ANDA) | March 23, 2012 |
| Chartwell Governmental & Specialty RX, LLC. | 4 | solution; suspension | Generic drugs (ANDA) | June 5, 2002 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | June 17, 2016 |
| Golden State Medical Supply, Inc. | 4 | tablet | Generic drugs (ANDA) | October 7, 2025 |
| Golden State Medical Supply, Inc. | 4 | tablet, extended release; tablet | Generic drugs (ANDA) | March 31, 2009 |
| Nordic Pharma, Inc. | 4 | tablet | Generic drugs (ANDA) | February 14, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | January 27, 2009 |
| Par Health USA, LLC | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | December 16, 2015 |
| Par Health USA, LLC | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | January 2, 2026 |
| Proficient Rx LP | 4 | tablet, extended release; tablet | Generic drugs (ANDA) | June 26, 2024 |
| Proficient Rx LP | 4 | tablet, delayed release; tablet | Generic drugs (ANDA) | November 1, 2011 |
| Quallent Pharmaceuticals Health LLC | 4 | tablet | Generic drugs (ANDA) | August 3, 2023 |
| ScieGen Pharmaceuticals, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | November 30, 2015 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet, delayed release; tablet | Generic drugs (ANDA) | July 8, 2010 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | capsule, liquid filled; tablet | Generic drugs (ANDA) | July 15, 2016 |
| Bostal LLC | 3 | tablet, extended release | Generic drugs (ANDA) | March 31, 2022 |
| Epic Pharma, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | June 3, 2024 |
| Ingenus Pharmaceuticals, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | August 1, 2023 |
| Newton Laboratories, Inc. | 3 | liquid; pellet | Unapproved homeopathic products | September 2, 2019 |
| Northwind Health Company, LLC | 3 | tablet; tablet, delayed release | Generic drugs (ANDA) | February 6, 2023 |
| Nutritional Specialties, Inc. | 3 | spray | Unapproved homeopathic products | October 5, 2023 |
| Precision Dose, Inc. | 3 | suspension; solution | Generic drugs (ANDA) | October 9, 2026 |
| Rising Pharma Holdings, Inc. | 3 | tablet, delayed release | Generic drugs (ANDA) | October 24, 2014 |
| Takeda Pharmaceuticals America, Inc. | 3 | capsule, extended release | New drug applications (NDA) | December 22, 1999 |
| Validus Pharmaceuticals LLC | 3 | capsule, extended release | New drug applications (NDA) | December 10, 2004 |
| Boiron | 2 | pellet | Unapproved homeopathic products | March 3, 1983 |
| Dna Labs, Inc. | 2 | solution | Unapproved homeopathic products | January 1, 1990 |
| Energetix Corporation | 2 | liquid | Unapproved homeopathic products | June 10, 2016 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | August 18, 2003 |
| Golden State Medical Supply, Inc. | 2 | tablet; tablet, chewable | Generic drugs (ANDA) | February 27, 2002 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection | Generic drugs (ANDA) | April 15, 2013 |
| King Bio Inc. | 2 | liquid | Unapproved homeopathic products | March 15, 2026 |
| Mylan Institutional Inc. | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | February 3, 2009 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | February 2, 2009 |
| Nivagen Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | April 21, 2020 |
| Oryza Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | May 18, 2026 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | November 1, 2011 |
| Rising Pharma Holdings, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | March 1, 2018 |
| Safecor Health, LLC | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | February 24, 2026 |
| St. Mary's Medical Park Pharmacy | 2 | tablet, delayed release | Generic drugs (ANDA) | May 13, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 196 | 22.1% |
| Tablet, extended release | 138 | 15.6% |
| Tablet, film coated, extended release | 105 | 11.9% |
| Tablet, delayed release | 92 | 10.4% |
| Pellet | 77 | 8.7% |
| Liquid | 59 | 6.7% |
| Tablet, orally disintegrating | 41 | 4.6% |
| Capsule | 31 | 3.5% |
| Solution | 28 | 3.2% |
| Capsule, extended release | 27 | 3.1% |
| Tablet, chewable | 24 | 2.7% |
| Capsule, gelatin coated | 13 | 1.5% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.